Sarah Boyce

Sarah Boyce is a highly accomplished professional with a diverse background in the pharmaceutical industry. She pursued her education at The University of Manchester, where she gained valuable insights into her field.

Currently serving as the President and CEO at Avidity Biosciences, Inc., Sarah leads the company with her extensive expertise and vision. Prior to this role, she held key positions at various renowned organizations, showcasing her versatile skills and leadership capabilities.

Sarah Boyce's career journey includes significant roles such as President at Akcea Therapeutics, Chief Business Officer and Senior Vice President at Ionis Pharmaceuticals, and Vice President focusing on international business strategy and operations at Forest Laboratories. Her rich experience at Alexion Pharmaceuticals, Novartis Vaccines and Diagnostics, as well as her time overseeing markets in Australia, New Zealand, and the United States, has honed her strategic acumen and global perspective.

Having excelled in roles ranging from marketing and business development to executive leadership, Sarah Boyce has a proven track record of driving growth and innovation in the pharmaceutical sector. Her time at Novartis Vaccines and Diagnostics, where she served as Marketing Director in the UK and later as Executive Director in the US, highlights her adaptability and expertise in diverse market landscapes.

Sarah Boyce's current position as President and CEO at Avidity Biosciences, Inc. serves as a testament to her strong leadership qualities and her ability to steer organizations towards success in a competitive industry.

With her remarkable career trajectory and wealth of experience, Sarah Boyce continues to make a significant impact in the pharmaceutical and biotechnology sectors, setting a high standard for leadership and innovation.